• FDA Takes Action to Address Epipen Shortages americanpharmaceuticalreview
    August 24, 2018
    The U.S. Food and Drug Administration (FDA) took additional action to mitigate shortages of EpiPen (epinephrine) auto-injector by extending the expiration date of specific lots of 0.3 milligram products marketed by Mylan by four months beyond the labeled
PharmaSources Customer Service